Sonova Holding AG
SIX:SOON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sonova Holding AG
SIX:SOON
|
CH |
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
S
|
Sands China Ltd
XMUN:599A
|
MO |
|
G
|
Guangdong Investment Ltd
XMUN:GUG
|
HK |
|
S
|
Synchrony Financial
F:SFE
|
US |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
Intrinsic Value
Is SOON undervalued or overvalued?
See the intrinsic value estimate for Sonova Holding AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SOON looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with SOON’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Sonova Does
Sonova Holding AG makes hearing care products and services. It designs and sells hearing aids, cochlear implants, wireless communication systems, and related accessories under brands used by hearing-care professionals and end customers. The company also offers audiology services and support tools that help people test, fit, and maintain their hearing devices.
- Headquarters
- Switzerland CH
- Employees
- 18 580
- IPO date
- Apr 23, 2009
Sonova Holding has no economic moat
Several established manufacturers offer competing hearing aids, and Sonova sells through independent providers as well as its own stores. Buyers and providers can therefore choose alternatives; Sonova’s brands and size alone do not keep rivals from winning sales.
Read the full moat analysis
Earnings Waterfall
Sonova Holding AG
The intrinsic value for Sonova Holding AG (SOON) under the Base Case is hidden CHF.
Compared with the current market price of 281 CHF, the stock appears hidden.